Glucocorticosteroid compound having anti-inflammatory activity

Details Glucocorticosteroid compound having anti-inflammatory activity Glucocorticosteroid compound having anti-inflammatory activity

2007-09-28

2009-12-29

Badio, Barbara P (Department: 1612)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

C514S171000, C514S180000, C552S610000

Reexamination Certificate

active

07638508

ABSTRACT:
A compound of formula (I):whereinX represents O or S;R1represents C1-6alkyl, C3-8cycloalkyl, C3-8cycloalkylmethyl or C3-8cycloalkenyl any of which optionally may be substituted by one or more methyl groups or halogen atoms or R1represents aryl, substituted aryl, heteroaryl or substituted heteroaryl;R2represents hydrogen, methyl, which may be in either the α or β configuration, or methylene;R3and R4are the same or different and each independently represents hydrogen, halogen or a methyl group;and represents a single or a double bond;or a physiologically acceptable salt or solvate thereof, andpharmaceutical formulations and methods of use thereof.

REFERENCES:
patent: 3856828 (1974-12-01), Phillipps et al.
patent: 4996335 (1991-02-01), Bodor et al.
patent: 5552438 (1996-09-01), Christensen, IV
patent: 6172054 (2001-01-01), Clark
patent: 6245804 (2001-06-01), Lehmann et al.
patent: 6395738 (2002-05-01), Ohshima et al.
patent: 6897224 (2005-05-01), Jaroch et al.
patent: 7288536 (2007-10-01), Biggadike et al.
patent: 7291609 (2007-11-01), Biggadike et al.
patent: 1384372 (1975-02-01), None
patent: 1384732 (1975-02-01), None
patent: 1514476 (1978-06-01), None
patent: 2079755 (1982-01-01), None
patent: 2137206 (1984-10-01), None
patent: 8903390 (1989-04-01), None
patent: 9313055 (1993-07-01), None
patent: 9534534 (1995-12-01), None
patent: 9741867 (1997-11-01), None
patent: 9830537 (1998-07-01), None
patent: 9854159 (1998-12-01), None
patent: 9916766 (1999-04-01), None
patent: 9932127 (1999-07-01), None
patent: 9947505 (1999-09-01), None
patent: 9962875 (1999-12-01), None
patent: 0066590 (2000-11-01), None
patent: 0104118 (2001-01-01), None
patent: 0110143 (2001-02-01), None
patent: 0116128 (2001-03-01), None
patent: 0142193 (2001-06-01), None
patent: 0200679 (2002-01-01), None
patent: 0202565 (2002-01-01), None
patent: 0226722 (2002-04-01), None
patent: 0240030 (2002-05-01), None
patent: 0250021 (2002-06-01), None
patent: 02066422 (2002-08-01), None
patent: 02070490 (2002-09-01), None
patent: 02076933 (2002-10-01), None
patent: 03008277 (2003-01-01), None
patent: 03024439 (2003-03-01), None
patent: 03042160 (2003-05-01), None
patent: 03059899 (2003-07-01), None
patent: 03061651 (2003-07-01), None
patent: 03072539 (2003-09-01), None
patent: 03082280 (2003-10-01), None
patent: 03082787 (2003-10-01), None
patent: 03082827 (2003-10-01), None
patent: 03086294 (2003-10-01), None
patent: 03091204 (2003-11-01), None
patent: 03101932 (2003-12-01), None
patent: 03104195 (2003-12-01), None
patent: 2004005229 (2004-01-01), None
patent: 2004009016 (2004-01-01), None
patent: 2004009017 (2004-01-01), None
patent: 2004016578 (2004-02-01), None
patent: 2004018429 (2004-03-01), None
patent: 2004022547 (2004-03-01), None
patent: 2004024728 (2004-03-01), None
patent: 2004026248 (2004-04-01), None
patent: 2004037768 (2004-05-01), None
patent: 2004037773 (2004-05-01), None
patent: 2004037807 (2004-05-01), None
patent: 2004039762 (2004-05-01), None
patent: 2004039766 (2004-05-01), None
patent: 2004056823 (2004-07-01), None
patent: 2004103998 (2004-12-01), None
patent: 2005005451 (2005-01-01), None
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-218 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Vippagunta et al. (Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26).
Szelenyi et al.; “Loteprednol Etabonate: a Soft Steroid for the Treatment of Allergic Diseases of the Airways”; Drugs of Today; 2000; vol. 36, No. 5; pp. 313-320.
Ueno et al.; “Synthesis and Evaluation of Anti-inflammatory Activities of a Series of Corticosteroid 17a-Esters Containing a Functional Group”; Journal of Medicinal Chemistry; 1991; vol. 34, No. 8; pp. 2468-2473.
Austin et al.; “Mometasone Furoate is a Less Specific Glucocorticoid than Fluticasone Propionate”; Eur. Resp. J.; 2002; vol. 20, No. 6; pp. 1386-1392.
Fujii et al.; “Novel Phosphodiesterase 4 Inhibitor T-440 Reverses and Prevents Human Bronchial Contraction Induced by Allergen”; J. Pharmacol. Exp. Ther.; 1998; vol. 284, No. 1; p. 162-169.
Landells et al.; “Oral Administration of the Phosphodiesterase (PDE)4 Inhibitor, V11294A Inhibits Ex-Vivo Agonist-Induced Cell Activation” (Annu Cong Eur Resp Soc, Sep. 22, 1998); Eur. Resp. J.; 1998; vol. 12, Suppl. 28; Abstract P2393, p. 362s.
Phillipps et al.; “Synthesis and Structure-Activity Relationships in a Series of Anti-inflammatory Corticosteroid Analogues, Halomethyl Androstane-17B-carbothioates and -17B-carboselenoates”; J. Med. Chem.; 1994; vol. 37, No. 22; pp. 3717-3729.
Rachwal et al.; “Chemistry of Ioteprednol etabonate and related steroids. II. Reactions at ring C and NMR structural studies of the resulting compounds”; Steroids; 1998; vol. 63, No. 4; pp. 193-201.
Ray et al.; “Induction of the E-Selectin Promoter by Interleukin 1 and Tumor Necrosis Factor x, and Inhibition by Glucocorticoids”; Biochem. J.; 1997; vol. 328; pp. 707-715.
Druzgala et al.; “Soft Drugs—10. Blanching Activity and Receptor Binding Affinity of a New Type of Glucocorticoid: Loteprednol Etabonate”; J. Steroid Biochem. Molec. Biol.; 1991; vol. 38, No. 2; pp. 149-154.

Affiliated with

Also associated with

Rating

Glucocorticosteroid compound having anti-inflammatory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glucocorticosteroid compound having anti-inflammatory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocorticosteroid compound having anti-inflammatory activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4078703